{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:17:47Z","timestamp":1786465067249,"version":"build-2736575974"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R61NS119639"],"award-info":[{"award-number":["R61NS119639"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1186\/s12014-026-09613-4","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T02:05:56Z","timestamp":1780711556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantitative tandem mass tag-based serum proteomics for longitudinal biomarker monitoring in Duchenne muscular dystrophy"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8884-9967","authenticated-orcid":false,"given":"Ahmed","family":"Naveed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa","family":"Recinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexter","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Degan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roula","family":"Tsonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Guglieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Al-Khalili Szigyarto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Spitali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri E. M.","family":"van der Burgt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Diaz-Manera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utkarsh J.","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"FOR-DMD investigators of the Muscle Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yetrib","family":"Hathout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"2","key":"9613_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mus.20586","volume":"34","author":"A Aartsma-Rus","year":"2006","unstructured":"Aartsma-Rus A, Van Deutekom JCT, Fokkema IF, Van Ommen GJB, Den Dunnen JT. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve. 2006;34(2):135\u201344. https:\/\/doi.org\/10.1002\/mus.20586.","journal-title":"Muscle Nerve"},{"issue":"28","key":"9613_CR2","doi-asserted-by":"publisher","first-page":"15664","DOI":"10.1073\/pnas.1910456117","volume":"117","author":"R Garc\u00eda-Rodr\u00edguez","year":"2020","unstructured":"Garc\u00eda-Rodr\u00edguez R, Hiller M, Jim\u00e9nez-Gracia L, van der Pal Z, Balog J, Adamzek K, et al. Premature termination codons in the DMD gene cause reduced local mRNA synthesis. Proc Natl Acad Sci U S A. 2020;117(28):15664\u20136464. https:\/\/doi.org\/10.1073\/pnas.1910456117.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"9613_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1083\/JCB.122.4.809","volume":"122","author":"JM Ervasti","year":"1993","unstructured":"Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol. 1993;122(4):809\u201323. https:\/\/doi.org\/10.1083\/JCB.122.4.809 . PubMed PMID: 8349731.","journal-title":"J Cell Biol"},{"issue":"1","key":"9613_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0887-8994(95)00251-0","volume":"14","author":"BJ Boland","year":"1996","unstructured":"Boland BJ, Silbert PL, Groover RV, Wollan PC, Silverstein MD. Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy. Pediatr Neurol. 1996;14(1):7\u201312. https:\/\/doi.org\/10.1016\/0887-8994(95)00251-0.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"9613_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/S13395-018-0177-7","volume":"8","author":"EM Houang","year":"2018","unstructured":"Houang EM, Sham YY, Bates FS, Metzger JM. Muscle membrane integrity in Duchenne muscular dystrophy: recent advances in copolymer-based muscle membrane stabilizers. Skeletal Muscle. 2018;8(1):31. https:\/\/doi.org\/10.1186\/S13395-018-0177-7.","journal-title":"Skeletal Muscle"},{"issue":"8","key":"9613_CR6","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1007\/S00415-023-11796-X","volume":"270","author":"M Chang","year":"2023","unstructured":"Chang M, Cai Y, Gao Z, Chen X, Liu B, Zhang C, et al. Duchenne muscular dystrophy: pathogenesis and promising therapies. J Neurol. 2023;270(8):3733\u201349. https:\/\/doi.org\/10.1007\/S00415-023-11796-X.","journal-title":"J Neurol"},{"key":"9613_CR7","doi-asserted-by":"publisher","first-page":"1183101","DOI":"10.3389\/FPHYS.2023.1183101","volume":"14","author":"A Bez Batti Angulski","year":"2023","unstructured":"Bez Batti Angulski A, Hosny N, Cohen H, Martin AA, Hahn D, Bauer J, et al. Duchenne muscular dystrophy: disease mechanism and therapeutic strategies. Front Physiol. 2023;14:1183101. . https:\/\/doi.org\/10.3389\/FPHYS.2023.1183101","journal-title":"Front Physiol"},{"issue":"2","key":"9613_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/PRI.520","volume":"17","author":"E Scott","year":"2012","unstructured":"Scott E, Eagle M, Mayhew A, Freeman J, Main M, Sheehan J, et al. Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy. Physiother Res Int. 2012;17(2):101\u20139. https:\/\/doi.org\/10.1002\/PRI.520.","journal-title":"Physiother Res Int"},{"issue":"6","key":"9613_CR9","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1002\/MUS.21808","volume":"42","author":"CM Mcdonald","year":"2010","unstructured":"Mcdonald CM, Henricson EK, Han JJ, Abresch RT, Nicorici A, Atkinson L, et al. The 6-minute walk test in Duchenne\/Becker muscular dystrophy: longitudinal observations. Muscle Nerve. 2010;42(6):966\u201374. https:\/\/doi.org\/10.1002\/MUS.21808.","journal-title":"Muscle Nerve"},{"issue":"15","key":"9613_CR10","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1001\/JAMA.2022.4315","volume":"327","author":"M Guglieri","year":"2022","unstructured":"Guglieri M, Bushby K, McDermott MP, Hart KA, Tawil R, Martens WB, et al. Effect of different corticosteroid dosing regimens on clinical outcomes in boys with Duchenne muscular dystrophy: a randomized clinical trial. JAMA. 2022;327(15):1456\u201368. https:\/\/doi.org\/10.1001\/JAMA.2022.4315.","journal-title":"JAMA"},{"issue":"9","key":"9613_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/J.NMD.2014.06.224","volume":"24","author":"LN Alfano","year":"2014","unstructured":"Alfano LN, Lowes LP, Berry KM, Yin H, Dvorchik I, Flanigan KM, et al. T.P.1: Pilot study evaluating motivation on the performance of timed walking in boys with Duchenne muscular dystrophy. Neuromuscul Disord. 2014;24(9):860. https:\/\/doi.org\/10.1016\/J.NMD.2014.06.224.","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"9613_CR12","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/J.NMD.2009.06.368","volume":"19","author":"ES Mazzone","year":"2009","unstructured":"Mazzone ES, Messina S, Vasco G, Main M, Eagle M, D\u2019Amico A, et al. Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Dis. 2009;19(7):458\u201361. https:\/\/doi.org\/10.1016\/J.NMD.2009.06.368.","journal-title":"Neuromuscul Dis"},{"key":"9613_CR13","doi-asserted-by":"publisher","DOI":"10.2147\/DNND.S121099","volume":"8","author":"CAK Szigyarto","year":"2018","unstructured":"Szigyarto CAK, Spitali P. Biomarkers of Duchenne muscular dystrophy: current findings. Degener Neurol Neuromuscul Dis. 2018;8:1. https:\/\/doi.org\/10.2147\/DNND.S121099.","journal-title":"Degener Neurol Neuromuscul Dis"},{"issue":"1","key":"9613_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS25010631","volume":"25","author":"M Molinaro","year":"2024","unstructured":"Molinaro M, Torrente Y, Villa C, Farini A. Advancing biomarker discovery and therapeutic targets in Duchenne Muscular Dystrophy: a comprehensive review. Int J Mol Sci. 2024;25(1):631. https:\/\/doi.org\/10.3390\/IJMS25010631.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"9613_CR15","doi-asserted-by":"publisher","DOI":"10.3233\/JND-190454","volume":"7","author":"K Strandberg","year":"2020","unstructured":"Strandberg K, Ayoglu B, Roos A, Reza M, Niks E, Signorelli M, et al. Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy. J Neuromuscul Dis. 2020;7(3):231. https:\/\/doi.org\/10.3233\/JND-190454.","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"9613_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64146-y","volume":"16","author":"NA Ikelaar","year":"2025","unstructured":"Ikelaar NA, Barnard AM, Eng SWM, Hosseini Vajargah S, Ha KCH, Kan HE, et al. Large-scale serum protein biomarkers discovery associated with function and clinical milestones in Duchenne muscular dystrophy. Nat Commun. 2025;16(1):9073-. https:\/\/doi.org\/10.1038\/s41467-025-64146-y.","journal-title":"Nat Commun"},{"issue":"1","key":"9613_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-23758-6","volume":"15","author":"F Ahmadiharchegani","year":"2025","unstructured":"Ahmadiharchegani F, Tobin RA, Degan C, Naveed A, Guglieri M, Jim\u00e9nez-Requena A, et al. Circulating protein biomarkers identified in two independent clinical trial cohorts of glucocorticoid-naive Duchenne muscular dystrophy patients. Sci Rep. 2025;15(1):39997-. https:\/\/doi.org\/10.1038\/s41598-025-23758-6.","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"9613_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jim.2009.06.003","volume":"347","author":"AN Hoofnagle","year":"2009","unstructured":"Hoofnagle AN, Wener MH. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J Immunol Methods. 2009;347(1\u20132):3\u201311. https:\/\/doi.org\/10.1016\/j.jim.2009.06.003.","journal-title":"J Immunol Methods"},{"issue":"22","key":"9613_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.036823","volume":"138","author":"A Joshi","year":"2018","unstructured":"Joshi A, Mayr M. In aptamers they trust: The caveats of the SOMAscan biomarker discovery platform from SomaLogic. Circulation. 2018;138(22):2482. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036823.","journal-title":"Circulation"},{"issue":"1","key":"9613_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/S13395-025-00385-3","volume":"15","author":"C Johansson","year":"2025","unstructured":"Johansson C, Schrama EJ, Kotol D, Hober A, Koeks Z, van de Velde NM, et al. Contrasting Becker and Duchenne muscular dystrophy serum biomarker candidates by using data independent acquisition LC-MS\/MS. Skeletal Muscle. 2025;15(1):15. https:\/\/doi.org\/10.1186\/S13395-025-00385-3.","journal-title":"Skeletal Muscle"},{"issue":"1","key":"9613_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/S13195-022-01113-5","volume":"14","author":"EB Dammer","year":"2022","unstructured":"Dammer EB, Ping L, Duong DM, Modeste ES, Seyfried NT, Lah JJ, et al. Multi-platform proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome. Alzheimers Res Ther. 2022;14(1):174. https:\/\/doi.org\/10.1186\/S13195-022-01113-5.","journal-title":"Alzheimers Res Ther"},{"issue":"41","key":"9613_CR22","doi-asserted-by":"publisher","first-page":"26504","DOI":"10.1021\/ACSOMEGA.0C03206","volume":"5","author":"TD Alayi","year":"2020","unstructured":"Alayi TD, Tawalbeh SM, Ogundele M, Smith HR, Samsel AM, Barbieri ML, et al. Tandem mass tag-based serum proteome profiling for biomarker discovery in young Duchenne Muscular Dystrophy boys. ACS Omega. 2020;5(41):26504\u201317. https:\/\/doi.org\/10.1021\/ACSOMEGA.0C03206.","journal-title":"ACS Omega"},{"issue":"19","key":"9613_CR23","doi-asserted-by":"publisher","DOI":"10.1021\/ACSOMEGA.1C00776","volume":"6","author":"C Hutchinson-Bunch","year":"2021","unstructured":"Hutchinson-Bunch C, Sanford JA, Hansen JR, Gritsenko MA, Rodland KD, Piehowski PD, et al. Assessment of TMT labeling efficiency in large-scale quantitative proteomics: The critical effect of sample pH. ACS Omega. 2021;6(19):12660. https:\/\/doi.org\/10.1021\/ACSOMEGA.1C00776.","journal-title":"ACS Omega"},{"issue":"1","key":"9613_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/S12014-022-09354-0","volume":"19","author":"S Weiner","year":"2022","unstructured":"Weiner S, Sauer M, Visser PJ, Tijms BM, Vorontsov E, Blennow K, et al. Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer\u2019s disease biomarkers. Clin Proteomics. 2022;19(1):13. https:\/\/doi.org\/10.1186\/S12014-022-09354-0.","journal-title":"Clin Proteomics"},{"issue":"1","key":"9613_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/JSS.V067.I01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, M\u00e4chler M, Bolker BM, Walker SC. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1\u201348. https:\/\/doi.org\/10.18637\/JSS.V067.I01.","journal-title":"J Stat Softw"},{"issue":"13","key":"9613_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/JSS.V082.I13","volume":"82","author":"A Kuznetsova","year":"2017","unstructured":"Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest package: Tests in linear mixed effects models. J Stat Softw. 2017;82(13):1\u201326. https:\/\/doi.org\/10.18637\/JSS.V082.I13.","journal-title":"J Stat Softw"},{"key":"9613_CR27","doi-asserted-by":"publisher","DOI":"10.64898\/2025.12.18.25342544","author":"C Degan","year":"2026","unstructured":"Degan C, Tobin RA, de Vries SI, Jim\u00e9nez-Requena A, Peco A, Guglieri M, et al. Evaluation of a serum protein signature as monitoring biomarker for Duchenne Muscular Dystrophy in a long-term clinical trial with corticosteroids. medRxiv. 2026. https:\/\/doi.org\/10.64898\/2025.12.18.25342544.","journal-title":"medRxiv"},{"issue":"1","key":"9613_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/J.2517-6161.1995.TB02031.X","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol. 1995;57(1):289\u2013300. . https:\/\/doi.org\/10.1111\/J.2517-6161.1995.TB02031.X","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"issue":"14","key":"9613_CR29","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1093\/HMG\/DDP191","volume":"18","author":"H Li","year":"2009","unstructured":"Li H, Mittal A, Makonchuk DY, Bhatnagar S, Kumar A. Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy. Hum Mol Genet. 2009;18(14):2584\u201398. https:\/\/doi.org\/10.1093\/HMG\/DDP191.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"9613_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17982-y","volume":"7","author":"A Lourbakos","year":"2017","unstructured":"Lourbakos A, Yau N, De Bruijn P, Hiller M, Kozaczynska K, Jean-Baptiste R, et al. Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne. Sci Rep. 2017;7(1):17888-. https:\/\/doi.org\/10.1038\/s41598-017-17982-y.","journal-title":"Sci Rep"},{"key":"9613_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2016.11.016","volume":"152","author":"CW Liu","year":"2016","unstructured":"Liu CW, Bramer L, Webb-Robertson BJ, Waugh K, Rewers MJ, Zhang Q. Temporal profiles of plasma proteome during childhood development. J Proteomics. 2016;152:321. https:\/\/doi.org\/10.1016\/j.jprot.2016.11.016.","journal-title":"J Proteomics"},{"issue":"3","key":"9613_CR32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrm2125","volume":"8","author":"A Page-McCaw","year":"2007","unstructured":"Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8(3):221\u201333. https:\/\/doi.org\/10.1038\/nrm2125.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"9613_CR33","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/JCSM.12304","volume":"9","author":"P Spitali","year":"2018","unstructured":"Spitali P, Hettne K, Tsonaka R, Charrout M, van den Bergen J, Koeks Z, et al. Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies. J Cachexia Sarcopenia Muscle. 2018;9(4):715\u201326. https:\/\/doi.org\/10.1002\/JCSM.12304.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"9613_CR34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1432-1033.1986.tb09586.x","volume":"156","author":"I Clemmensen","year":"1986","unstructured":"Clemmensen I, Petersen LC, Kluft C. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: Tetranectin. Eur J Biochem. 1986;156(2):327\u201333 (TB09586.X PubMed PMID: 3009181).","journal-title":"Eur J Biochem"},{"issue":"2","key":"9613_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1006\/dbio.1998.8962","volume":"200","author":"UM Wewer","year":"1998","unstructured":"Wewer UM, Kousuke I, Durkin ME, Nielsen FC, Loechel F, Gilpin BJ, et al. Tetranectin is a novel marker for myogenesis during embryonic development, muscle regeneration, and muscle cell differentiation in vitro. Dev Biol. 1998;200(2):247\u201359. https:\/\/doi.org\/10.1006\/dbio.1998.8962.","journal-title":"Dev Biol"},{"issue":"3","key":"9613_CR36","doi-asserted-by":"publisher","DOI":"10.1152\/AJPCELL.00344.2014","volume":"309","author":"TC Ho","year":"2015","unstructured":"Ho TC, Chiang YP, Chuang CK, Chen SL, Hsieh JW, Lan YW, et al. PEDF-derived peptide promotes skeletal muscle regeneration through its mitogenic effect on muscle progenitor cells. Am J Physiol Cell Physiol. 2015;309(3):C159. https:\/\/doi.org\/10.1152\/AJPCELL.00344.2014.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"9613_CR37","volume":"28","author":"E Abdel-Salam","year":"2009","unstructured":"Abdel-Salam E, Abdel-Meguid I, Korraa SS. Markers of degeneration and regeneration in Duchenne muscular dystrophy. Acta Myol. 2009;28(3):94.","journal-title":"Acta Myol"},{"issue":"10","key":"9613_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/BIOLOGY10101056","volume":"10","author":"A Kaczmarek","year":"2021","unstructured":"Kaczmarek A, Kaczmarek M, Cia\u0142owicz M, Clemente FM, Wola\u0144ski P, Badicu G, et al. The role of satellite cells in skeletal muscle regeneration\u2014the effect of exercise and age. Biology (Basel). 2021;10(10):1056. https:\/\/doi.org\/10.3390\/BIOLOGY10101056.","journal-title":"Biology (Basel)"},{"issue":"3","key":"9613_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/HUMU.9364","volume":"26","author":"R Cagliani","year":"2005","unstructured":"Cagliani R, Magri F, Toscano A, Merlini L, Fortunato F, Lamperti C, et al. Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies. Hum Mutat. 2005;26(3):283. https:\/\/doi.org\/10.1002\/HUMU.9364.","journal-title":"Hum Mutat"},{"issue":"5","key":"9613_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/CTD2.240","volume":"3","author":"VG Kayejo","year":"2023","unstructured":"Kayejo VG, Fellner H, Thapa R, Keyel PA. Translational implications of targeting annexin A2: from membrane repair to muscular dystrophy, cardiovascular disease and cancer. Clin Transl Discov. 2023;3(5):e240. https:\/\/doi.org\/10.1002\/CTD2.240.","journal-title":"Clin Transl Discov"},{"key":"9613_CR41","doi-asserted-by":"publisher","DOI":"10.1101\/2025.09.23.677988","author":"M Quang","year":"2025","unstructured":"Quang M, Le, d\u2019Agata L, Rassinoux P, Ruiz J, Gounou C, Salesses A, et al. Duchenne muscular dystrophy is driven by defective membrane repair and annexin-A2 dysregulation in skeletal muscle. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.09.23.677988.","journal-title":"bioRxiv"},{"issue":"1","key":"9613_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10438-z","volume":"10","author":"MW Hogarth","year":"2019","unstructured":"Hogarth MW, Defour A, Lazarski C, Gallardo E, Manera JD, Partridge TA, et al. Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B. Nat Commun. 2019;10(1):2430-. https:\/\/doi.org\/10.1038\/s41467-019-10438-z.","journal-title":"Nat Commun"},{"issue":"9","key":"9613_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS19092516","volume":"19","author":"E Piktel","year":"2018","unstructured":"Piktel E, Levental I, Durna\u015b B, Janmey PA, Bucki R. Plasma gelsolin: indicator of inflammation and its potential as a diagnostic tool and therapeutic target. Int J Mol Sci. 2018;19(9):2516. https:\/\/doi.org\/10.3390\/IJMS19092516.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9613_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-019-48548-9","volume":"9","author":"Y Hathout","year":"2019","unstructured":"Hathout Y, Liang C, Ogundele M, Xu G, Tawalbeh SM, Dang UJ, et al. Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy. Sci Rep. 2019;9(1):12167. https:\/\/doi.org\/10.1038\/S41598-019-48548-9.","journal-title":"Sci Rep"},{"issue":"3","key":"9613_CR45","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1172\/JCI112634","volume":"78","author":"SE Lind","year":"1986","unstructured":"Lind SE, Smith DB, Janmey PA, Stossel TP. Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation. J Clin Invest. 1986;78(3):736\u201342. https:\/\/doi.org\/10.1172\/JCI112634.","journal-title":"J Clin Invest"},{"issue":"23","key":"9613_CR46","doi-asserted-by":"publisher","first-page":"6756","DOI":"10.1093\/HMG\/DDV381","volume":"24","author":"TC Roberts","year":"2015","unstructured":"Roberts TC, Johansson HJ, McClorey G, Godfrey C, Blomberg EKM, Coursindel T, et al. Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration. Hum Mol Genet. 2015;24(23):6756\u201368. https:\/\/doi.org\/10.1093\/HMG\/DDV381.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"9613_CR47","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1074\/MCP.RA120.002345","volume":"19","author":"TLE van Westering","year":"2020","unstructured":"van Westering TLE, Johansson HJ, Hanson B, Coenen-Stass AML, Lomonosova Y, Tanihata J, et al. Mutation-independent proteomic signatures of pathological progression in murine models of Duchenne Muscular Dystrophy. Mol Cell Proteomics. 2020;19(12):2047\u201368. https:\/\/doi.org\/10.1074\/MCP.RA120.002345.","journal-title":"Mol Cell Proteomics"},{"issue":"3","key":"9613_CR48","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1113\/JPHYSIOL.1938.SP003605","volume":"92","author":"ECB Smith","year":"1938","unstructured":"Smith ECB. The buffering of muscle in rigor; protein, phosphate and carnosine. J Physiol. 1938;92(3):336\u201343. https:\/\/doi.org\/10.1113\/JPHYSIOL.1938.SP003605.","journal-title":"J Physiol"},{"issue":"2","key":"9613_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUDIS.2023.103860","volume":"29","author":"K Chmielewska","year":"2024","unstructured":"Chmielewska K, Vittorio S, Gervasoni S, Dzierzbicka K, Inkielewicz-Stepniak I, Vistoli G. Human carnosinases: a brief history, medicinal relevance, and in silico analyses. Drug Discov Today. 2024;29(2):103860. https:\/\/doi.org\/10.1016\/J.DRUDIS.2023.103860.","journal-title":"Drug Discov Today"},{"issue":"4","key":"9613_CR50","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1152\/PHYSREV.00039.2012\/ASSET\/IMAGES\/LARGE\/Z9J0041326720019.JPEG","volume":"93","author":"AA Boldyrev","year":"2013","unstructured":"Boldyrev AA, Aldini G, Derave W. Physiology and pathophysiology of carnosine. Physiol Rev. 2013;93(4):1803\u201345. https:\/\/doi.org\/10.1152\/PHYSREV.00039.2012\/ASSET\/IMAGES\/LARGE\/Z9J0041326720019.JPEG.","journal-title":"Physiol Rev"},{"issue":"2","key":"9613_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/JCM9020520","volume":"9","author":"ML Law","year":"2020","unstructured":"Law ML, Cohen H, Martin AA, Angulski ABB, Metzger JM. Dysregulation of calcium handling in Duchenne muscular dystrophy-associated dilated cardiomyopathy: mechanisms and experimental therapeutic strategies. J Clin Med. 2020;9(2):520. https:\/\/doi.org\/10.3390\/JCM9020520.","journal-title":"J Clin Med"},{"key":"9613_CR52","doi-asserted-by":"publisher","unstructured":"Dudley RWR, Khairallah M, Mohammed S, Lands L, Des Rosiers C, Petrof BJ. Dynamic responses of the glutathione system to acute oxidative stress in dystrophic mouse (mdx) muscles. Am J Physiol Regul Integr Comp Physiol. 2006;291(3). https:\/\/doi.org\/10.1152\/AJPREGU.00031.2006. JPEG PubMed PMID: 16614063.","DOI":"10.1152\/AJPREGU.00031.2006"},{"issue":"2","key":"9613_CR53","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/mus.880100208","volume":"10","author":"IM Burr","year":"1987","unstructured":"Burr IM, Asayama K, Fenichel GM. Superoxide dismutases, glutathione peroxidase, and catalase in neuromuscular disease. Muscle Nerve. 1987;10(2):150\u20134. 10. 1002\/MUS.880100208 PubMed PMID: 3821787.","journal-title":"Muscle Nerve"},{"issue":"1","key":"9613_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/PRCA.200900116","volume":"4","author":"C Colussi","year":"2010","unstructured":"Colussi C, Banfi C, Brioschi M, Tremoli E, Straino S, Spallotta F, et al. Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatment. Proteomics Clin Appl. 2010;4(1):71\u201383. https:\/\/doi.org\/10.1002\/PRCA.200900116.","journal-title":"Proteomics Clin Appl"},{"issue":"2","key":"9613_CR55","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/S00011-022-01679-8","volume":"72","author":"M Kurano","year":"2023","unstructured":"Kurano M, Tsukamoto K, Kamitsuji S, Kamatani N, Hasegawa K, Hara M, et al. Apolipoprotein D modulates lipid mediators and osteopontin in an anti-inflammatory direction. Inflamm Res. 2023;72(2):263\u201380. https:\/\/doi.org\/10.1007\/S00011-022-01679-8.","journal-title":"Inflamm Res"},{"issue":"4","key":"9613_CR56","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/J.1474-9726.2008.00395.X","volume":"7","author":"MD Ganfornina","year":"2008","unstructured":"Ganfornina MD, Do Carmo S, Lora JM, Torres-Schumann S, Vogel M, Allhorn M, et al. Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress. Aging Cell. 2008;7(4):506\u201315. https:\/\/doi.org\/10.1111\/J.1474-9726.2008.00395.X.","journal-title":"Aging Cell"},{"issue":"4","key":"9613_CR57","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1074-7613(00)80254-X","volume":"4","author":"A Haziot","year":"1996","unstructured":"Haziot A, Ferrero E, K\u00f6ntgen F, Hijiya N, Yamamoto S, Silver J, et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity. 1996;4(4):407\u201314. https:\/\/doi.org\/10.1016\/S1074-7613(00)80254-X.","journal-title":"Immunity"},{"key":"9613_CR58","unstructured":"CD14 -. Monocyte differentiation antigen CD14 - Homo sapiens (Human) | UniProtKB | UniProt [Internet]. [cited 2026 Jan 7]. Available from: https:\/\/www.uniprot.org\/uniprotkb\/P08571\/entry"},{"issue":"7","key":"9613_CR59","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1152\/ajplung.00093.2013","volume":"305","author":"SC Christiaans","year":"2013","unstructured":"Christiaans SC, Wagener BM, Esmon CT, Pittet JF. Protein C and acute inflammation: a clinical and biological perspective. Am J Physiol Lung Cell Mol Physiol. 2013;305(7):455\u201366. https:\/\/doi.org\/10.1152\/ajplung.00093.2013.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"9613_CR60","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.thromres.2015.01.011","volume":"135","author":"KB Kov\u00e1cs","year":"2015","unstructured":"Kov\u00e1cs KB, Pataki I, B\u00e1rdos H, Fekete A, Pfliegler G, Haramura G, et al. Molecular characterization of p.Asp77Gly and the novel p.Ala163Val and p.Ala163Glu mutations causing protein C deficiency. Thromb Res. 2015;135(4):718\u201326. https:\/\/doi.org\/10.1016\/j.thromres.2015.01.011.","journal-title":"Thromb Res"},{"issue":"1","key":"9613_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/srep31727","volume":"6","author":"Y Hathout","year":"2016","unstructured":"Hathout Y, Conklin LS, Seol H, Gordish-Dressman H, Brown KJ, Morgenroth LP, et al. Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children. Sci Rep. 2016;6(1):31727-. https:\/\/doi.org\/10.1038\/srep31727.","journal-title":"Sci Rep"},{"key":"9613_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003725.pub4","author":"E Matthews","year":"2016","unstructured":"Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY. Corticosteroids for the treatment of Duchenne Muscular Dystrophy. Cochrane Database Syst Rev. 2016. https:\/\/doi.org\/10.1002\/14651858.CD003725.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"9613_CR63","doi-asserted-by":"publisher","first-page":"8774","DOI":"10.1038\/s41467-025-64501-z","volume":"16","author":"U Distler","year":"2025","unstructured":"Distler U, Yoo HB, Kardell O, Hein D, Sielaff M, Scherer M, et al. Multicenter evaluation of label-free quantification in human plasma on a high dynamic range benchmark set. Nat Commun. 2025;16(1):8774. https:\/\/doi.org\/10.1038\/s41467-025-64501-z.","journal-title":"Nat Commun"},{"issue":"D1","key":"9613_CR64","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/NAR\/GKAE1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol Y, Bandla C, Kundu DJ, Kamatchinathan S, Bai J, Hewapathirana S, et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 2025;53(D1):D543-53. https:\/\/doi.org\/10.1093\/NAR\/GKAE1011.","journal-title":"Nucleic Acids Res"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12014-026-09613-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-026-09613-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-026-09613-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T14:03:32Z","timestamp":1786457012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12014-026-09613-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["9613"],"URL":"https:\/\/doi.org\/10.1186\/s12014-026-09613-4","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The FOR-DMD study was registered at ClinicalTrials.gov (registration no. NCT01603407). Serum samples and clinical data were collected following approval from the competent ethics committee at each institution in accordance with the International Conference on Harmonisation guidelines for Good Clinical Practice and the World Medical Association Declaration of Helsinki. Central Institutional Review Board (IRB) approval for the original FOR-DMD study was obtained from the University of Rochester Ethics Committee\/IRB and the Newcastle Clinical Trial Unit (NCTU) before the distribution of study documents to each investigative site and the enrollment of participants. Informed written consent for participation in biomarker research was obtained from the parents or legal guardians of participants at the time of enrollment in the clinical study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"42"}}